Cosmo Pharmaceuticals N.V. (LON:0RGI)
London · Delayed Price · Currency is GBP · Price in CHF 116.00
+0.60 (0.52%)
Feb 12, 2026, 5:04 PM GMT
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 1.75 billion as of February 12, 2026. Its market cap has increased by 89.31% in one year.
Market Cap
1.75B
Enterprise Value
1.65B
Revenue
156.24M
Ranking
n/a
PE Ratio
34.08
Stock Price
116.00
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 82.45M to 1.75B, an increase of 2,025.77%. That is a compound annual growth rate of 17.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.75B | 11.02% |
| Dec 30, 2025 | 1.57B | 74.80% |
| Dec 30, 2024 | 900.54M | 18.04% |
| Dec 29, 2023 | 762.90M | -15.23% |
| Dec 30, 2022 | 899.97M | 0.53% |
| Dec 30, 2021 | 895.23M | -12.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 11.10B |
| Hikma Pharmaceuticals | 3.48B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.29B |